The gp130 signaling pathway plays a crucial role in regulating cardiac myocyte growth, myocardial remodeling, and cytoprotection in cardiovascular diseases.
Answers are grounded in this paper and cite their sources.
Gp130 signaling remains preclinical for cardiac remodeling; leaves open targeted interventions pending clinical trials.
Interleukin (IL)-6-related cytokines share gp130 as the signal-transducing protein. Cardiac myocytes produce various kinds of cytokines including IL-6 and cardiotrophin-1. Activation of gp130 transduces hypertrophic and cytoprotective signals in cardiac myocytes via JAK/STAT, MAP kinase and PI-3 kinase pathways. Besides various well-established mechanisms by which cardiac growth and myocardial remodeling are regulated, gp130 signalling may be a newly discovered mechanism that regulates these events in association with cytoprotective effect in myocardial diseases.
No takes yet. Share an insight, caveat, or question.
Yamauchi‐Takihara et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: